Tatsuro Fukuhara Selected Research

Irinotecan (Camptosar)

1/2021	Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401).
3/2013	Phase II study of irinotecan as a third- or fourth-line treatment for advanced non-small cell lung cancer: NJLCG0703.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuro Fukuhara Research Topics

Disease

23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 07/2006
22	Neoplasms (Cancer) 12/2023 - 01/2005
5	Adenocarcinoma of Lung 11/2023 - 04/2008
5	Disease Progression 08/2023 - 01/2015
5	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2008
3	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2008
2	Carcinoma (Carcinomatosis) 12/2023 - 04/2022
2	Adenocarcinoma 01/2014 - 03/2008
1	Neuroendocrine Carcinoma 12/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Exanthema (Rash) 01/2019
1	Neutropenia 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 07/2018
1	Myasthenia Gravis 07/2018
1	Brain Neoplasms (Brain Tumor) 01/2015
1	Esophagitis 01/2015
1	Neuritis (Polyneuritis) 11/2014
1	Optic Neuritis (Retrobulbar Neuritis) 11/2014
1	Ovarian Neoplasms (Ovarian Cancer) 04/2014
1	Carcinogenesis 04/2014
1	Pneumonia (Pneumonitis) 08/2008
1	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2008
1	Meningeal Carcinomatosis 04/2008
1	Colonic Neoplasms (Colon Cancer) 04/2006
1	Melanoma (Melanoma, Malignant) 04/2006

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 08/2023 - 07/2006
9	Tyrosine Kinase InhibitorsIBA 08/2023 - 04/2008
4	NivolumabIBA 01/2024 - 07/2018
4	B7-H1 AntigenIBA 10/2023 - 03/2019
4	pembrolizumabIBA 08/2023 - 03/2019
4	Gefitinib (Iressa)FDA Link 10/2020 - 07/2006
3	IpilimumabIBA 01/2024 - 10/2023
3	osimertinibIBA 11/2023 - 08/2023
3	Bevacizumab (Avastin)FDA Link 04/2022 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 01/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 03/2013
2	CarcinogensIBA 12/2018 - 04/2014
2	Anaplastic Lymphoma KinaseIBA 01/2015 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 11/2014 - 08/2008
2	Urethane (Ethyl Carbamate)IBA 04/2014 - 05/2008
2	Secretory Leukocyte Peptidase InhibitorIBA 04/2014 - 05/2008
2	Epidermal Growth Factor (EGF)IBA 08/2008 - 04/2008
1	Niacin (Nicotinic Acid)FDA LinkGeneric 12/2023
1	Culture MediaIBA 12/2023
1	nicotinate-nucleotide diphosphorylase (carboxylating)IBA 12/2023
1	nicotinamide riboside kinaseIBA 12/2023
1	NAD (NADH)IBA 12/2023
1	Nicotinamide PhosphoribosyltransferaseIBA 12/2023
1	Cell-Free Nucleic AcidsIBA 11/2023
1	PlatinumIBA 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 04/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2022
1	menaquinone 6 FDA Link 11/2021
1	AlbuminsIBA 11/2021
1	Serum AlbuminIBA 11/2021
1	Pemetrexed (MTA)FDA Link 02/2021
1	UracilIBA 02/2021
1	TegafurIBA 02/2021
1	amrubicinIBA 01/2021
1	Monoclonal AntibodiesIBA 03/2019
1	LigandsIBA 03/2019
1	CarbonIBA 12/2018
1	Glucose (Dextrose)FDA LinkGeneric 12/2018
1	AfatinibIBA 12/2018
1	Protein Isoforms (Isoforms)IBA 12/2018
1	CrizotinibIBA 01/2015
1	Retinaldehyde (Retinal)IBA 11/2014
1	AntibodiesIBA 11/2014
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 04/2014
1	NF-kappa B (NF-kB)IBA 04/2014
1	Small Interfering RNA (siRNA)IBA 04/2014
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2014
1	Surface-Active Agents (Surfactants)IBA 08/2008
1	LipopolysaccharidesIBA 08/2008
1	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 08/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2008
1	Codon (Codons)IBA 04/2008
1	Phosphotransferases (Kinase)IBA 03/2008
1	DNA (Deoxyribonucleic Acid)IBA 07/2006
1	Chemokine CX3CL1IBA 04/2006
1	InterleukinsIBA 01/2005
1	CytokinesIBA 01/2005
1	Interleukin-4 (Interleukin 4)IBA 01/2005
1	VaccinesIBA 01/2005
1	Interleukin-12 (IL 12)IBA 01/2005

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2024 - 07/2006
8	Therapeutics 12/2023 - 05/2015
3	Immunotherapy 01/2024 - 01/2005
1	Diet Therapy (Therapy, Diet) 12/2023
1	Transplantation 12/2023
1	Aftercare (After-Treatment) 08/2023
1	Radiotherapy 02/2021
1	Chemoradiotherapy 02/2021
1	Cranial Irradiation 12/2015
1	Intranasal Administration 08/2008